Proprietary Neoantigen Identification Technology Platform

admin

7 years ago

Johanna Bendell, MD of Sarah Cannon Research Institute discusses the Proprietary Neoantigen Identification Technology Platform at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.